English

This infographic demonstrates the social impact of living with hepatitis B.

This infographic demonstrates the physical toll of living with hepatitis B.

Free to use, downloadable mpox content. Share on social media, embed on websites, link to in e-communications, and more.

This webinar recording discusses how to reduce disparities in hepatitis, research and community partnerships have been essential in reaching at-risk and underserved populations by addressing the adverse social determinants that are responsible for these disparities. For example, successful collaborations often simplify and facilitate access and linkage to care. In many cases, communities are considered as program recipients or research subjects instead of critical partners who should be significant contributors to the design and implementation of an initiative.

This video presentation by the San Francisco Department of Public Health (SFDPH) on implementation of Doxy-PEP in a single clinic which offered Doxy-PEP to all clients using HIV PrEP and saw bacterial STIs decrease among those who used Doxy-PEP by nearly 60% in less than a year, with the highest declines for syphilis (78%) and chlamydia (67%).

This webinar discusses how every year, 1.3 million people lose their lives to hepatitis – because they weren’t tested, or didn’t have access to treatment, or were never vaccinated. And new data from the World Health Organization shows the number of deaths is rising. 

This guideline discusses the interim recommendations for the use of doxycycline for post-exposure prophylaxis (doxy PEP) for the prevention of certain bacterial sexually transmitted infections (STIs).

This fact sheet from the NYC Department of Health and Mental Hygiene discusses how Doxy PEP can be used for STI prevention.

This fact sheet discusses how doxy PEP can be used for STI prevention.